 REHOVOT, Israel, Nov. 03, 2021 GLOBE NEWSWIRE -- Purple Biotech Ltd. Purple Biotech , or the Company NASDAQTASE: PPBT, a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, today announced that management will present a corporate overview at the Jefferies London Healthcare Conference on Wednesday, November 17, 2021 at 12:20 pm GMT. The conference will take place from November 16 - 19, 2021. Management will be available for one-on-one meetings. 